INVESTIGATIONAL NEW DRUG APPLICATIONS
\ɪnvˌɛstɪɡˈe͡ɪʃənə͡l njˈuː dɹˈʌɡ ˌaplɪkˈe͡ɪʃənz], \ɪnvˌɛstɪɡˈeɪʃənəl njˈuː dɹˈʌɡ ˌaplɪkˈeɪʃənz], \ɪ_n_v_ˌɛ_s_t_ɪ_ɡ_ˈeɪ_ʃ_ə_n_əl n_j_ˈuː d_ɹ_ˈʌ_ɡ ˌa_p_l_ɪ_k_ˈeɪ_ʃ_ə_n_z]\
Sort: Oldest first
-
An application that must be submitted to a regulatory agency (the FDA in the United States) before a drug can be studied in humans. This application includes results of previous experiments; how, where, and by whom the new studies will be conducted; the chemical structure of the compound; how it is thought to work in the body; any toxic effects found in animal studies; and how the compound is manufactured. (From the "New Medicines in Development" Series produced by the Pharmaceutical Manufacturers Association and published irregularly.)
By DataStellar Co., Ltd
Word of the day
Platidiam
- An inorganic water-soluble platinum complex. After undergoing hydrolysis, it reacts DNA produce both intra interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity cisplatin correlates with cellular arrest in G2 phase cell cycle.